PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
I believe patients deserve more than a list of side effects. They deserve evidence-based strategies to prepare for treatment, manage symptoms, recover afterward, and improve their quality of life.
This guide reviews what FOLFOX is, how it works, common and long-term side effects, and the complementary therapies supported by research that may help you navigate treatment.
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Before beginning Folfox therapy, consider:
Scroll down the page and post a question or a comment if there’s anything you’d like to know about Folfox for Cancer..
Good luck,
David Emerson
| Feature | Details |
|---|---|
| Regimen | FOLFOX |
| Drugs | Oxaliplatin + Leucovorin (Folinic Acid) + 5-Fluorouracil (5-FU) |
| Common cancers | Colon, rectal, gastric, esophageal, pancreatic (selected patients) |
| Typical cycle | Every 14 days |
| Infusion length | Approximately 46 hours with a portable infusion pump |
| Main toxicities | Neuropathy, fatigue, nausea, diarrhea, low blood counts, mouth sores |
FOLFOX combines three medications that attack cancer cells in different ways:
Oxaliplatin
A platinum-based chemotherapy that damages cancer cell DNA, preventing cells from dividing.
Leucovorin (Folinic Acid)
Not chemotherapy itself. It enhances the effectiveness of 5-FU.
5-Fluorouracil (5-FU)
One of the oldest and most effective chemotherapy drugs. It interferes with DNA synthesis in rapidly dividing cancer cells.
FOLFOX is commonly prescribed for:
Cancer cells divide rapidly.
FOLFOX attacks this process in multiple ways:
Using several drugs together makes it more difficult for cancer cells to survive or develop resistance.
Most patients receive treatment every two weeks.
Day 1
Days 2–3
Continuous infusion of 5-FU through the pump.
Day 3
Pump disconnected.
Days 4–13
Recovery period before the next cycle.
| Side Effect | Approximate Frequency |
| Fatigue | Very common |
| Nausea | Common |
| Diarrhea | Common |
| Mouth sores | Common |
| Low white blood cells | Common |
| Low platelets | Common |
| Cold sensitivity | Very common |
| Peripheral neuropathy | Very common |
| Loss of appetite | Common |
| Taste changes | Common |
One of the hallmarks of oxaliplatin is cold-induced neuropathy.
Patients often notice:
For many patients, these symptoms improve between cycles early in treatment. However, with cumulative doses, neuropathy can become persistent or permanent.
Potential long-term complications include:
| Side Effect | Evidence-Based Prevention Strategies |
| Neuropathy | Report symptoms early, regular exercise, discuss dose adjustments with your oncology team, maintain adequate nutrition; cryotherapy during infusion is being studied and may be appropriate in some centers |
| Mouth sores | Salt/baking soda rinses, good oral hygiene, hydration |
| Fatigue | Walking, resistance exercise, sleep optimization, adequate protein intake |
| Nausea | Preventive anti-nausea medications, ginger, small frequent meals |
| Diarrhea | Early use of anti-diarrheal medication as directed, hydration, low-fiber foods during acute episodes |
| Infection | Hand hygiene, prompt evaluation of fever, vaccination when appropriate, adequate nutrition |
Exercise
Perhaps the single most studied complementary therapy during chemotherapy.
Research consistently shows exercise helps reduce:
Aim for:
Nutrition
Patients should focus on:
If diarrhea occurs, temporary adjustments to a lower-fiber diet may be helpful until symptoms improve.
Peripheral Neuropathy
Growing evidence supports:
Currently, duloxetine is the medication with the strongest evidence for treating established chemotherapy-induced peripheral neuropathy.
Evidence supports:
These approaches may help reduce:
Sleep Optimization
Patients who sleep well generally report:
Sleep hygiene should be considered part of cancer treatment.
Vitamin D
Vitamin D deficiency is common among cancer patients.
Recovery varies considerably.
Most patients notice:
Within weeks
Within months
Longer term
Neuropathy may:
Is FOLFOX curative?
For many patients with Stage III colon cancer after surgery, FOLFOX is given with curative intent. For metastatic disease, the goal is often to control cancer, prolong survival, and maintain quality of life.
Will I lose my hair?
Complete hair loss is uncommon with FOLFOX, although hair thinning can occur.
Can neuropathy become permanent?
Yes. The risk increases with cumulative oxaliplatin exposure. Early communication with your oncology team about numbness or tingling is important.
Can I exercise during treatment?
For most patients, yes. Regular physical activity is associated with reduced fatigue, improved function, and better quality of life. Exercise plans should be individualized with your healthcare team.
Cardiotoxicity related side effects-
| Therapy | Evidence | Recommendation |
| Exercise | ⭐⭐⭐⭐⭐ | Strongly recommended for most patients |
| Nutrition optimization | ⭐⭐⭐⭐⭐ | Strongly recommended |
| Duloxetine for established CIPN | ⭐⭐⭐⭐☆ | Consider for painful neuropathy |
| Acupuncture | ⭐⭐⭐☆☆ | May benefit selected patients |
| Mindfulness/MBSR | ⭐⭐⭐⭐☆ | Helpful for anxiety, sleep, and stress |
| Vitamin D (if deficient) | ⭐⭐⭐☆☆ | Correct deficiency under medical supervision |
| Cryotherapy during oxaliplatin infusion | ⭐⭐☆☆☆ | Promising but evidence remains mixed; discuss with your oncology team |
| Dietary supplements marketed for neuropathy prevention | ⭐☆☆☆☆ | Insufficient evidence for routine use; review all supplements with your oncology team |